KLP Kapitalforvaltning AS Makes New Investment in LENZ Therapeutics, Inc. (NASDAQ:LENZ)

KLP Kapitalforvaltning AS purchased a new position in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,600 shares of the company’s stock, valued at approximately $46,000. Several other hedge […]